Welke Karl F
Mary Bridge Children's Hospital, Multicare Health System, Tacoma, WA, USA.
World J Pediatr Congenit Heart Surg. 2010 Jul;1(2):194-8. doi: 10.1177/2150135110372530.
As interest in measuring the cost and quality of health care has increased, congenital cardiac surgery has increasingly been scrutinized. To accurately assess the performance of one's own congenital cardiac program and to interpret data presented by outside entities, an understanding of the available metrics and their limitations is essential. Our ability to assess quality in congenital cardiac surgery is constrained by the data and evidence available. Evaluating the surgical patient in the context of all patients with congenital cardiac disease will help determine the effectiveness of a program's broader approach. Tracking of long-term outcomes, including morbidity, mortality, neurological status, and functional status will help focus attention on the results and the timeline that matter most to patients and their families. Defining structural and process measures that affect outcome not only may improve the results of congenital cardiac surgery but may lead to improvement in other patient populations that share hospital resources.
随着对医疗保健成本和质量测量的关注度不断提高，先天性心脏手术受到了越来越多的审视。为了准确评估自身先天性心脏项目的表现，并解读外部机构提供的数据，了解可用的指标及其局限性至关重要。我们评估先天性心脏手术质量的能力受到现有数据和证据的限制。在所有先天性心脏病患者的背景下评估手术患者，将有助于确定一个项目更广泛方法的有效性。跟踪长期结果，包括发病率、死亡率、神经状态和功能状态，将有助于将注意力集中在对患者及其家庭最重要的结果和时间线上。定义影响结果的结构和过程指标，不仅可能改善先天性心脏手术的结果，还可能导致共享医院资源的其他患者群体的情况得到改善。
